화학공학소재연구정보센터
홈 로그인 로그아웃 연락처 사이트맵
Macromolecular Research, Vol.17, No.2, 99-103, February, 2009
Export Citation
Evaluation of the Anti-Tumor Effects of Paclitaxel-Encapsulated pH-Sensitive Micelles
Jong Kwon Han, Min Sang Kim, Doo Sung Lee†, Yoo-Shin Kim1, Rang-Woon Park1, Kwangmeyung Kim2, and Ick Chan Kwon2
  • Department of Polymer Science and Engineering, Sungkyunkwan University, Gyeonggi 440-746, Korea
  • 1Department of Biochemistry and Advanced Medical Technology Cluster for Diagnosis and Prediction,School of Medicine, Kyungpook National University, Daegu 700-422, Korea
  • 2Biomedical Research Center, Korea Institute of Science and Technology, Seoul 136-719, Korea
E-mail:
We evaluated the efficacy of pH-sensitive micelles, formed by methoxy poly(ethylene glycol)-b-poly(β-amino ester) (PEG-PAE), as carriers for paclitaxel (PTX), a drug currently used to treat various cancers. PTX was successful encapsulated by a film hydration method. Micelles encapsulated more than 70% of the PTX and the size of the PTX-encapsulated micelles (PTX-PM) was less than 150 nm. In vitro experiments indicated that the micelles were unstable below pH 6.5. After encapsulation of PTX within the micelles, dynamic light scattering (DLS) studies indicated that low pH had a similar demicellization effect. An in vitro release study indicated that PTX was slowly released at pH 7.4 (normal body conditions) but rapidly released under weakly acidic conditions (pH 6.0). We demonstrated the safety of micelles from in vitro cytotoxicity tests on HeLa cells and the in vivo anti-tumor activity of PTX-PM in B16F10 tumor-bearing mice. We concluded that these pH-sensitive micelles have potential as carriers for anti-cancer drugs.
Keywords:paclitaxel;pH sensitive;micelle.
  1. Kwon GS, Kataoka K, Adv. Drug. Deliver. Rev., 16, 295 (1995)
  2. Kataoka K, Harada A, Nagasaki Y, Adv. Drug. Deliver. Rev., 47, 113 (2001)
  3. Jung YP, Son YK, Kim JH, Macromol. Res., 15(1), 82 (2007)
  4. Kim WJ, Kim SW, Macromol. Res., 15(2), 100 (2007)
  5. Kim SY, Cho SH, Lee YM, Chu LY, Macromol. Res., 15(7), 646 (2007)
  6. Jones MC, JC, Eur. J. Pharm. Biopharm., 48, 101 (1999)
  7. Kwon GS, Okano T, Adv. Drug. Deliver. Rev., 21, 107 (1996)
  8. Duncan R, Pharm. Sci. Technol. Today, 2, 441 (1999)
  9. Singla AK, Garg A, Aggarwal D, Int. J. Pharm., 235, 179 (2002)
  10. Zhang JA, Anyarambhatla G, Ma L, Ugwu S, Xuan T, Sardone T, Ahmad I, Eur. J. Pharm. Biopharm., 59, 177 (2005)
  11. Kim SC, Kim DW, Shim YH, Bang JS, Oh HS, Kim SW, Seo MH, J. Control. Release, 72, 191 (2001)
  12. Lee SC, Kim CH, Kwon IC, Chung H, Jeong SY, J. Control. Release, 89, 437 (2003)
  13. Kim TY, Kim DW, Chung JY, Shin SG, Kim SC, Heo DS, Kim NK, Bang YJ, Clin. Cancer Res., 10, 3708 (2004)
  14. Soga O, van Nostrum CF, Fens M, Rijcken CJF, Schiffelers RM, Storm G, Hennink WE, J. Control. Release, 103, 341 (2005)
  15. Kim JH, Kim YS, Kim SW, Park JH, Kim KM, Choi KW, Chung H, Jeong SY, Park RW, Kim IS, Kwon IC, J. Control. Release, 111, 228 (2006)
  16. Lee ES, Na K, Bae YH, Nano Lett., 5, 325 (2005)
  17. Stubbs M, McSheehy PMJM, Griffiths JR, Bashford CL, Mol. Med. Today, 6, 15 (2000)
  18. Kim MS, Hwang SJ, Han JK, Choi EK, Park HJ, Kim JS, Lee DS, Macromol. Rapid Commun., 27(6), 447 (2006)
  19. Hwang SJ, Kim MS, Han JK, Lee DS, Kim BS, Choi EK, Park HJ, Kim JS, Macromol. Res., 15(5), 437 (2007)
  20. Ko JY, Park KS, Kim YS, Kim MS, Han JK, Kim KM, Park RW, Kim IS, Song HK, Lee DS, Kwon IC, J. Control. Release, 123, 109 (2007)
  21. Lavasanifar A, Samuel J, Kwon GS, J. Control. Release, 77, 155 (2001)
  22. Willey TA, Bekos EJ, Gaver RC, Duncan GF, Tay LK, Beijnen JH, Farmen RH, J. Chromatogr., 621, 231 (1993)